Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Tralesinidase alfa | [1] Tralesinidase alfa Tralesinidase alfa (Tralesinidase alfa) | [1] Tralesinidase alfa
Tralesinidase alfa
(Tralesinidase alfa) 💬
| [2] IGF2 IGF2,NAGLU 💬 | [9] Glycosaminoglycan degradation Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬 | [1] 19 19 💬
|
| 2 | Tralesinidase alfa (TA) | [1] Tralesinidase alfa Tralesinidase alfa (Tralesinidase alfa) | [1] Tralesinidase alfa
Tralesinidase alfa
(Tralesinidase alfa) 💬
| [2] IGF2 IGF2,NAGLU 💬 | [9] Glycosaminoglycan degradation Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬 | [1] 19 19 💬
|
